A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study-Reference-Cited by-同舟云学术

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study

Published:2018-03-06 Issue:6 Volume:92 Page:1021-1027
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Nef Holger¹,Wiebe Jens²^ORCID,Boeder Niklas¹^ORCID,Dörr Oliver¹^ORCID,Bauer Timm¹,Hauptmann Karl-Eugen³,Latib Azeem⁴,Colombo Antonio⁴,Fischer Dieter⁵^ORCID,Rudolph Tanja⁶,Foin Nicolas⁷,Richardt Gert⁸,Hamm Christian¹

Affiliation:

1. Department of Cardiology and Angiology; University of Giessen, Medizinische Klinik I; Giessen Germany

2. Department of Cardiology; Deutsches Herzzentrum Muenchen; Munich Germany

3. Krankenhaus der Barmherzigen Brüder Trier; Trier Germany

4. Ospedale San Raffaele; Milan Italy

5. Department of Cardiology and Angiology; University of Münster; Münster Germany

6. Department of Cardiology; University of Cologne; Cologne Germany

7. National Heart Centre Singapore, Duke-NUS Medical School; Singapore, Singapore

8. Department of Cardiology; Segeberger Kliniken; Bad Segeberg Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.27550/fullpdf

Reference24 articles.

1. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization;Finn;Circulation,2007

2. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk;Joner;J Am Coll Cardiol,2006

3. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: The ABSORB cohort;Onuma;A Trial. JACC Cardiovasc Interv,2013

4. Evaluation of the ABSORB everolimus eluting bioresorbable vascular scaffold (ABSORB BVS) in the treatment of patients with de novo native coronary artery lesions: 2 Year clinical results of ABSORB cohort B trial;Dudek;J Am Coll Cardiol,2012

5. Everolimus-eluting bioresorbable scaffolds for coronary artery disease;Ellis;N Engl J Med,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioresorbable scaffolds: past and present. Clinical example of a 10-year follow-up of a patient with an implanted Absorb stent;Ateroscleroz;2024-07-05

2. A review on PLA-based biodegradable materials for biomedical applications;Giant;2024-06

3. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

4. Bioresorbable Poly (L-Lactic Acid) Flow Diverter Versus Cobalt-Chromium Flow Diverter: In Vitro and In Vivo Analysis;Stroke;2023-06

5. Bioresorbable scaffolds: current concepts and future technology;Iberoamerican Journal of Medicine;2022-08-31